• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Enovis completes Insight Medical acquisition

Enovis completes Insight Medical acquisition

July 6, 2022 By Sean Whooley

Insight Medical Systems and its Augmented Reality Visualization and Information System ARVIS Insight Medical Systems DJO augmented reality orthopedic surgery
The next-gen Augmented Reality Visualization and Information System (ARVIS) [Image courtesy of Insight Medical Systems]
Enovis (NYSE:ENOV) announced today that it acquired orthopedic surgical guidance company Insight Medical Systems.

Wilmington, Delaware-based Enovis — the parent company of DJO Global — did not disclose financial terms for the acquisition of Insight, which develops its flagship Arvis FDA-cleared augmented reality platform for hip and knee replacement surgery.

In March 2021, DJO as part of Enovis made a strategic investment in Insight Medical Systems and its Arvis (augmented reality visualization and information system) for orthopedic surgeries. There was a previous investment in 2020, and since that point, Arvis has received FDA 510(k) clearance and successfully completed more than 200 cases in the U.S.

“We are excited to welcome Insight’s talented team to our Enovis family where we will work together to improve patient outcomes through the use of next-generation augmented reality surgical guidance in orthopedic surgery,” Enovis CEO Matt Trerotola said in a news release. “Adding Insight’s technology to our rapidly growing surgical business advances our enabling technologies platform with innovation tailored to today’s healthcare economics and especially the ASC.”

Enovis said that Arvis will be made commercially available in the third quarter of 2022. The Insight team will become part of the Enovis surgical organization (previously DJO Surgical) and will work to drive further growth and expansion for the company’s orthopedic-enabling technologies platform.

“Arvis delivers real-time, hands-free surgical guidance at the point of care and is designed to generate measurably better patient outcomes in a streamlined, space-conserving and cost-effective manner compared to traditional robotic offerings,” Enovis COO Brady Shirley said. “Simply put, the Arvis augmented reality system represents the next era of orthopedic technology, and we look forward to expanding its features and reach while integrating additional joint replacement surgery capabilities in the future.”

Filed Under: Business/Financial News, Featured, Health Technology, Imaging, Mergers & Acquisitions, News Well, Orthopedics, Software / IT, Surgical Tagged With: Enovis, Insight Medical Systems

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy